Covid-19 roundup: Pfiz­er/BioN­Tech vac­cine on verge of EU au­tho­riza­tion; Cure­Vac launch­es PhI­II tri­al in health­care work­ers

It looks like the Eu­ro­pean Union may be get­ting the Pfiz­er/BioN­Tech vac­cine in time for the new year.

The EMA’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use on Mon­day rec­om­mend­ed the agency move for­ward with con­di­tion­al mar­ket­ing au­tho­riza­tion for the vac­cine, paving the way for some EU na­tions to start in­oc­u­lat­ing cit­i­zens as ear­ly as next week. Ma­jor mem­ber states, such as Ger­many, France, Aus­tria and Italy, had pre­vi­ous­ly said they plan to start vac­ci­na­tions on Dec. 27, should the shots be au­tho­rized.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER